TechConnect Summit 2011

New Strategies For Secure, Non-Invasive Transitional for Brain Cancer Treatment

Organization:SOCPRA, J1L 1E2, CA
I.P. Brief:The technology is used to reversibly open the BBB for an easier filtration of the brain cancer treatment essential substances. The invention describes natural peptide derived molecules with improved pharmacological profile and high therapeutic potential. These molecules are able to stimulate B1 human inducible specific receptor (rB1).
Keywords:Blood brain barrier, brain tumor, glioblastoma, adjuvant, cancer, therapy
Primary Industry:Pharmaceuticals

Full IP Descriptions available on-site.


TechConnect World 2011 Nanotech 2011 Clean Technology 2011 Microtech 2011 BioNanotech 2011 TechConnect Summit 2011
Program | Exhibit/Sponsor | Press | Venue | Register
Short Courses | News | Subscribe | Contact | Site Map
© Copyright 2010 TechConnect World. All Rights Reserved.